Kathleen Jaeger resigns as head of US generics group
This article was originally published in Scrip
Executive Summary
Kathleen Jaeger, the president and CEO of the US generics trade group GPhA, has resigned from her post, held since 2002, less than two weeks after the group's largest member, Teva Pharmaceutical Industries, announced it was pulling out of the association owing to objections over the group's current structure (scripnews.com, 26 April 2010).